See All Slides - tctmd.com

Slides

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Presenter: Daniel A Canos, Kazuhiro Sase

October 30, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

Presentation TCT 2017

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Presenter: Gregg W. Stone, Holger Thiele

October 30, 2017

Presentation TCT 2017

High-grade AV Block After ASA

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Presentation TCT 2017

Might Mitraclip Make Ablation Irrelevant?

Presenter: John S. Douglas Jr, Valerian Fernandes, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Advertisement

Slides

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

High-grade AV Block After ASA

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Might Mitraclip Make Ablation Irrelevant?

Should Alleviating ISCHEMIA Be the Goal?

Slovakia Presents: Case Conclusion - How I Treated This Case

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content